(NASDAQ: NOTV) Inotiv's forecast annual revenue growth rate of 5.15% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.5%.
Inotiv's revenue in 2025 is $475,114,000.On average, 1 Wall Street analysts forecast NOTV's revenue for 2025 to be $16,752,756,525, with the lowest NOTV revenue forecast at $16,752,756,525, and the highest NOTV revenue forecast at $16,752,756,525. On average, 1 Wall Street analysts forecast NOTV's revenue for 2026 to be $17,769,850,674, with the lowest NOTV revenue forecast at $17,769,850,674, and the highest NOTV revenue forecast at $17,769,850,674.
In 2027, NOTV is forecast to generate $18,852,312,511 in revenue, with the lowest revenue forecast at $18,852,312,511 and the highest revenue forecast at $18,852,312,511.